A 32-year-old man presents with a painless right testicular lump. Ultrasound confirms a 2.8 cm hypoechoic mass. Post-orchidectomy histology confirms pure seminoma, pT1, no lymphovascular invasion. CT thorax/abdomen/pelvis shows no retroperitoneal lymphadenopathy. AFP is normal; beta-hCG is mildly elevated. The tumor marker pattern (elevated beta-hCG in 'pure seminoma') is explained by:
- A Contamination with non-seminomatous germ cell components missed on histology
- B Leydig cell component producing beta-hCG
- C Syncytiotrophoblastic giant cells within the seminoma producing beta-hCG ✓
- D Cross-reactivity of AFP with beta-hCG assay
Explanation
Pure seminoma may contain syncytiotrophoblastic giant cells (STGCs) — large multinucleate cells that produce beta-hCG. This explains mild beta-hCG elevation (typically <200 mIU/mL) in histologically confirmed pure seminoma without any non-seminomatous component. STGCs do NOT change the diagnosis to non-seminomatous GCT (NSGCT) or mixed GCT — pure seminoma management is maintained. AFP elevation in apparent 'seminoma' mandates treating as NSGCT even if histology seems pure, because AFP is produced only by yolk sac/embryonal components. Mild beta-hCG elevation in pure seminoma carries a slightly worse prognosis.
Reference: Bailey & Love's Short Practice of Surgery, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.